新入荷 再入荷

61Vc+c-LNbL._AC_UF1000,,Pharmacokinetic-Pharmacodynamic Modeling and Simulation,Pharmacokinetic-Pharmacodynamic Modeling and Simulation,Population pharmacokinetic modeling and simulation of,Development of a Minimalistic Physiologically Based,Abstracts for the Ninth American Conference on,Defining preclinical efficacy with the DNAPK inhibitor,PK/PD modeling of a clazosentan thorough QT study with,Mechanistic Pharmacokinetic/Pharmacodynamic Modeling in,Pharmacokinetic-Pharmacodynamic Modeling and Simulation,Pharmacokinetic–Pharmacodynamic Modeling and Simulation in,Pharmacokinetic-Pharmacodynamic Modeling and Simulation,Physiologically-based pharmacokinetic modeling for optimal,Machine Learning for Pharmacokinetic/Pharmacodynamic,Pharmacokinetic–pharmacodynamic modeling of maintenance